This week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.

Flush with Trump connections, Ballard Partners is D.C.’s new lobbying powerhouse — and its clients are reaping the benefits.

People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...

GLP-1 weight-loss drugs are popular but pricey. New data highlights use by age and gender - and why interest outpaces access for many.

When Robyn Yerian founded The Bird’s Nest back in 2022, affordability was her main concern. Yerian — divorced, mother of two, ...

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

The Trump administration faces an arduous task of encouraging states to expand Medicaid coverage of expensive anti-obesity ...

Trump demands U.S. drug prices match lowest international rates for some or face executive action. This article originally ...

The Trump administration is launching a pressure campaign against prescription drugmakers in an effort to get them to lower ...

Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.

Medicare Advantage usage trends reveal slight declines in 2023, highlighting critical insights for policymakers amid rising ...

Eli Lilly's stock is lagging the S&P 500 since April, potentially allowing a catch-up trade if results impress. Medicare may ...